
Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five ... Vistagen Therapeutics Inc is a biotechnology firm. The company is in its clinical stage and engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system. Vistagen's pipeline includes six product candidates, including five clinical-stage investigational agents belonging to a new class of drugs known as pherines. Its portfolio includes PH94B, a novel neuroactive nasal spray with therapeutic potential in a wide range of indications involving anxiety or phobia. PH10, an odorless, fast-acting synthetic neurosteroid for neuropsychiatric indications involving depression. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.53 | -18.2130584192 | 2.91 | 2.9599 | 2.35 | 123016 | 2.64308587 | CS |
4 | -0.07 | -2.85714285714 | 2.45 | 2.9599 | 2.35 | 126330 | 2.71387752 | CS |
12 | -0.84 | -26.0869565217 | 3.22 | 3.3492 | 2.35 | 165814 | 2.82882439 | CS |
26 | -0.62 | -20.6666666667 | 3 | 3.395 | 2.22 | 223075 | 2.81238074 | CS |
52 | -3.02 | -55.9259259259 | 5.4 | 5.74 | 2.22 | 181756 | 3.30877249 | CS |
156 | -34.52 | -93.5501355014 | 36.9 | 53.7 | 1.62 | 2916791 | 6.46886419 | CS |
260 | -10.82 | -81.9696969697 | 13.2 | 106.5 | 1.62 | 2498628 | 21.6825432 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約